LEADER 00748nam0 2200241 450 001 000002949 005 20181107145301.0 100 $a20010619d1949----km-y0itay50------ba 101 0 $aeng 102 $aUS 200 1 $aControlling factors in economic development$fby Harold G. Moulton 210 $aWashington$cBrookings institution$d1949 215 $aXII, 397 p.$cill.$d21 cm 610 1 $aSviluppo economico 610 1 $aReddito$aDistribuzione 610 1 $aDepressione economica 676 $a338.9 700 1$aMoulton,$bHarold G.$0130245 801 0$aIT$bUNIPARTHENOPE$gRICA$2UNIMARC 912 $a000002949 951 $cNAVA4$a338.9/101$b8885$d20010704 996 $aControlling factors in economic development$9501364 997 $aUNIPARTHENOPE LEADER 04786nam 2200733Ia 450 001 9910968043503321 005 20251116165701.0 010 $a9786610447237 010 $a9780309180344 010 $a0309180341 010 $a9781280447235 010 $a1280447230 010 $a9780309653046 010 $a0309653045 035 $a(CKB)1000000000245204 035 $a(SSID)ssj0000238661 035 $a(PQKBManifestationID)11220761 035 $a(PQKBTitleCode)TC0000238661 035 $a(PQKBWorkID)10233477 035 $a(PQKB)10084336 035 $a(MiAaPQ)EBC3378066 035 $a(Au-PeEL)EBL3378066 035 $a(CaPaEBR)ebr10120234 035 $a(CaONFJC)MIL44723 035 $a(OCoLC)923275192 035 $a(Perlego)4736967 035 $a(BIP)13173316 035 $a(EXLCZ)991000000000245204 100 $a20060427d2006 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 02$aA risk reduction strategy for human exploration of space $ea review of NASA's Bioastronautics Roadmap /$fDavid E. Longnecker and Ricardo A. Molins, editors 205 $a1st ed. 210 $aWashington, DC $cNational Academies Press$dc2006 215 $axvii, 143 p. $cill 300 $a"Committee on Review of NASA's Bioastronautics Roadmap, Board on Health Sciences Policy, Space Studies Board, Aeronautics and Space Engineering Board, Institute of Medicine and National Research Council of the National Academies." 300 $aAccompanied by CD-ROM, "Bioastronautics Roadmap." 311 08$a9780309099486 311 08$a030909948X 320 $aIncludes bibliographical references and index. 327 $aFrontMatter -- Independent Report Reviewers -- Contents -- List of Tables, Figures, and Boxes -- Executive Summary -- 1 Introduction -- 2 Considerations Regarding the BR Content -- 3 Considerations Regarding the BR Process -- 4 Considerations Regarding the BR Context -- APPENDIXES -- A Bibliography of Related National Academies Reports -- B Methods -- C Status of Countermeasure and Technology Readiness Levels -- D Bone Fracture Risk Associated with Prolonged Exposure to Microgravity -- E Integration of Data-Based Evidence and Expert Opinion in Decision Making -- F Biographical Sketches of Committee Members and Staff -- Index. 330 $aExtending the spatial and temporal boundaries of human space flight is an important goal for the nation and for the National Aeronautics and Space Administration (NASA). However, human space flight remains an endeavor with substantial risks, and these risks must be identified, managed, and mitigated appropriately to achieve the nation's goals in space. The Bioastronautics Roadmap (BR) is the result of extensive, commendable efforts on the part of NASA to prioritize research efforts to meet these challenges. In 2003, NASA asked the Institute of Medicine (IOM), in collaboration with the Division on Engineering and Physical Sciences of the National Academies, to conduct a review of the BR. Specifically, NASA asked the committee to (1) conduct a comprehensive assessment and report of the strengths and weaknesses of the content and processes of the Bioastronautics Roadmap as applied to the missions described in the President's exploration initiative and (2) identify the unique challenges for accomplishing its goals and objectives. In September 2004, the committee released its preliminary report to NASA entitled Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap . That document presented the committee's preliminary conclusions about the strengths and weaknesses of the April 2004 version of the BR. This report, A Risk Reductions Strategy for Human Exploration of Space , builds on those preliminary conclusions and provides recommendations to NASA about how to address the issues identified by the committee. 517 3 $aHuman exploration of space 606 $aSpace flight$xPhysiological effect 606 $aAstronauts$xHealth and hygiene 606 $aRisk management 615 0$aSpace flight$xPhysiological effect. 615 0$aAstronauts$xHealth and hygiene. 615 0$aRisk management. 676 $a616.9/80214 701 $aLongnecker$b David E.$f1939-$01805825 701 $aMolins$b Ricardo A.$f1948-$01805826 712 02$aInstitute of Medicine (U.S.).$bCommittee on Review of NASA's Bioastronautics Roadmap. 712 02$aNational Research Council (U.S.).$bCommittee on Review of NASA's Bioastronautics Roadmap. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910968043503321 996 $aA risk reduction strategy for human exploration of space$94354644 997 $aUNINA